Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

 

Enter Stock Symbol:  

Sierra Oncology Inc (SRRA)

2 0.01 (0.5%)

04-18 16:00

Open:

2

Pre. Close:

1.99

High:

2.08

Low:

1.9402

Volume:

443,395

Market Cap:

143M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

2.083 - 2.091

2.091 - 2.099

Low:

1.92 - 1.929

1.929 - 1.937

Close:

1.986 - 2

2 - 2.013

Technical analysis  (as of: 2018-04-18 4:44:36 PM)

Overall:

      

Stoxline posted a STRONG BUY today, upgraded from lower rating. This stock seems to be very strong for long buyers. If you bought, continue to hold stock until SELL signal. You are relatively safe as long as the SELL warning is not issued.

Target:

Six months: 2.63     One year: 2.94

Support:

Support1: 1.82    Support2: 1.51

Resistance:

Resistance1: 2.25    Resistance2: 2.52

Pivot:

2.02

Moving Averages:

MA(5): 1.96     MA(20): 2.06

MA(100): 2.79     MA(250): 2.02

MACD:

MACD(12,26): -0.13     Signal(12,26,9): -0.14

%K %D:

%K(14,3): 30.64     %D(3): 23.01

RSI:

RSI(14): 40.66

52-Week:

High: 4.09  Low: 1.1  Change(%): 47.1

Average Vol(K):

3-Month: 59357  10-Days 48496

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
SRRA has closed above bottom band by 43.2%. Bollinger Bands are 62.9% narrower than normal. The narrow width of the bands suggests low volatility as compared to SRRA's normal range. The bands have been in this narrow range for 10 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

2018-04-17T07:00:00-04:00
Sierra Late-Breaking Data Demonstrating SRA737 Preclinical Activity with PARPi to be Presented at the AACR 2018 Annual Meeting

2018-04-06T07:14:53-04:00
Key events next week - healthcare

2018-04-05T17:37:13-04:00
After Hours Gainers / Losers (04/05/2018)

2018-03-27T14:34:23-04:00
Sierra Oncology (SRRA) Presents At BioCentury's 25th Annual Future Leaders In The Biotech Industry Conference - Slideshow

2018-03-19T07:00:00-04:00
Sierra Oncology to Present at the Future Leaders in the Biotech Industry Conference in New York

2018-03-14T16:51:00-04:00
Late-Breaking Abstract Reporting SRA737 Preclinical Activity in CCNE1-Driven and PARPi-Resistant Cancers Accepted for AACR 2018 Annual Meeting

2018-03-08T15:33:44-05:00
Due Diligence Ramp-Up: Sierra Oncology's DNA Damage Gamble

2018-03-02T09:18:14-05:00
Premarket Losers as of 9:05 am (3/2/2018)

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

NA

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Bio Therapeutic Drugs

Shares Out. (M)

52.45

Shares Float (M)

52.05

% Held by Insiders

0.80

% Held by Institutions

70.10

Shares Short (K)

260

Shares Short Prior Month (K)

402

Stock Financials

EPS

-0.850

EPS Est. Current Year

-0.890

EPS Est. Next Year

-0.820

EPS Est. Next Quarter

-0.220

Forward EPS

-0.881

Book Value (p.s.)

1.100

PEG Ratio

-0.04

Profit Margin

Operating Margin

Return on Assets (ttm)

-39.4

Return on Equity (ttm)

-42.4

Qtrly Rev. Growth

Gross Profit (p.s.)

Sales Per Share

EBITDA (p.s.)

-0.602

Qtrly Earnings Growth

Operating Cash Flow (M)

-36.16

Levered Free Cash Flow (M)

-20.90

atoplab.com

Valuation

P/E

-2.35

P/E Growth Ratio

0.01

P/BV

1.82

P/S

P/CF

-2.90

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.